Cross-Sectional Study of Harmful Alcohol Use Among Acutely Ill Cardiac Patients of a Multidisciplinary Clinic

Nadezhdin A. V.
PhD, Assistant Professor, Chair for Addiction Medicine¹
ORCID 0000-0003-3368-3170

Tetenova E. J.
PhD, Assistant Professor, Chair for Addiction Medicine¹
ORCID 0000-0002-9390-621X

Petukhov A. E.
PhD (Pharmacy), Assistant Professor, A.P. Arzamastsev Chair for Pharmaceutical and Toxicological Chemistry, A.P. Nelyubin Institute of Pharmacy²
ORCID 0000-0002-4855-4235

Davydova E. N.
Deputy Head Physician³

1 - Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
2 - Sechenov First Moscow State Medical University, Moscow, Russian Federation
3 - Demikhov Moscow Clinical Hospital, Moscow, Russian Federation

Nadezhdin Aleksey; e-mail: aminazin@inbox.ru

None declared.

The study had no sponsorship.

Background. Alcohol use affects many aspects of the functioning of the cardiovascular system. It causes an increased risk of: hypertension; pathological conditions caused by disorders of generation and conduction of electrical signals in the myocardium; cardiovascular diseases such as ischaemic and haemorrhagic strokes. Aim of the study. To study the prevalence of alcohol consumption among acutely ill cardiac patients, not requiring intensive care, hospitalized in a multidisciplinary urban clinical hospital, using screening self-questionnaires (AUDIT-4) and a highly sensitive and specific marker of chronic alcohol intoxication phosphatidylethanol (PEth). Materials and Methods. Using AUDIT-4 and PEth, we studied the prevalence of alcohol use in cardiac patients with regard to their socio-demographic characteristics. Statistical analysis was performed using IBM SPSS Statistics 25.0 software. We applied descriptive statistics and logistic regression model to estimate adjusted odds ratio for socio-demographic and diagnostic cofactors associated with alcohol abuse. Study results. PEth values in peripheral blood of 0.3 µmol/l or more, indicating excessive alcohol consumption during 2-4 weeks prior to hospitalization, were noted in 8.9% of patients. At the same time, 3.0% of patients admitted the fact of alcohol consumption during the day preceding hospitalization. The presence of only one patient with a diagnosis of alcoholic cardiomyopathy is noteworthy. Negatively associated with PEth level ≥0.3 μmol/L were patients in age group ≥71 compared with patients aged 18-40 as the reference group, (AOR 0.058; CI 95% 0.009-0.379; p<0.003) and women compared with men (AOR 0.227, CI 95% 0,113-0,445; р<0,001). There was a positive association with PEth level ≥0.3 μmol/L for patients who defined their marital status as divorced/separated compared to the reference group married/married/civil partnership (AOR 2.535; CI 95% 1.218-5.276; p=0.013). A significant positive association with a PEth level ≥0.3 μmol/L (AOR 6.668; CI 95% 2.592-17.155; p<0.001) was observed in those who admitted drinking alcoholic beverages within 24 hours before hospitalization compared with the reference group who denied it. Diagnostic groups had no statistically significant associations with the outcome variable. Conclusions. Our findings support the need for brief anti-alcohol interventions by primary care physicians, especially when diagnosing alcohol-associated conditions in cardiac patients. It seems necessary to aim internists to work more carefully with diagnoses of alcohol-associated and alcohol-attributable conditions.

alcohol consumption, AUDIT-4, phosphatidylethanol, alcoholic cardiomyopathy, alcohol-associated disease, cardiological pathology, brief intervention

10.29234/2308-9113-2024-12-2-90-113

1. Global alcohol action plan 2022-2030 to strengthen implementation of the Global Strategy to Reduce the Harmful Use of Alcohol. First draft. June 2021. World Health Organization, 2021. Available at: https://cdn.who.int/media/docs/default-source/alcohol/alcohol-action-plan/first-draft/global­_alcohol­_acion­_plan­_first-draft­_july­_2021.pdf Accessed: 25.06.2023.

2. Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization; 2010. Available at: https://apps.who.int/iris/handle/10665/44395 Accessed: 25.06.2023.

3. Rehm J., Baliunas D., Borges G.L., Graham K., Irving H., Kehoe T., Parry C.D., Patra J., Popova S., Poznyak V., Roerecke M., Room R., Samokhvalov A.V., Taylor B. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010; 105(5): 817-843, doi: 10.1111/j.1360-0443.2010.02899.x

4. Molina P.E., Gardner J.D., Souza-Smith F.M., Whitaker A.M. Alcohol abuse: critical pathophysiological processes and contribution to disease burden. Physiology (Bethesda) 2014; 29(3): 203-215, doi: 10.1152/physiol.00055.2013

5. Narkologiya: Nacional'noe rukovodstvo. Kratkoe izdanie. [Addiction Medicine. National Guidelines. Concise edition] Moskva: «GEOTAR-Media», 2020. (In Russ.)

6. Zhou Y., Zheng J., Li S., Zhou T., Zhang P., Li H.B. Alcoholic Beverage Consumption and Chronic Diseases. Int J Environ Res Public Health 2016; 13(6): 522, doi: 10.3390/ijerph13060522

7. Piano M.R. Alcohol's Effects on the Cardiovascular System. Alcohol Res. 2017; 38(2): 219-241.

8. Rehm J., Roerecke M. Cardiovascular effects of alcohol consumption. Trends Cardiovasc Med. 2017; 27(8): 534-538, doi: 10.1016/j.tcm.2017.06.002

9. Gardner J.D., Mouton A.J. Alcohol effects on cardiac function. Compr Physiol. 2015; 5(2): 791-802, doi: 10.1002/cphy.c140046

10. Klatsky A.L. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015; 278(3): 238-250, doi: 10.1111/joim.12390

11. Chiva-Blanch G., Badimon L. Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies. Nutrients 2019; 12(1): 108, doi: 10.3390/nu12010108

12. di Castelnuovo A., Costanzo S., di Giuseppe R, de Gaetano G, Iacoviello L. Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives. Future Cardiol. 2009; 5(5): 467-477, doi: 10.2217/fca.09.36

13. Matsumoto C., Miedema M.D., Ofman P., Gaziano J.M., Sesso H.D. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev. 2014; 34(3): 159-171, doi: 10.1097/HCR.0000000000000042

14. Rosoff D.B., Davey Smith G., Mehta N., Clarke T.K., Lohoff F.W. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study. PLoS Med. 2020; 17(12): e1003410, doi: 10.1371/journal.pmed.1003410

15. Abrahao K.P., Salinas A.G., Lovinger D.M. Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. Neuron 2017; 96(6): 1223-1238, doi: 10.1016/j.neuron.2017.10.032

16. Zaridze D., Brennan P., Boreham J., Boroda A., Karpov R., Lazarev A., Konobeevskaya I., Igitov V., Terechova T., Boffetta P., Peto R. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet 2009; 373(9682): 2201-2214, doi: 10.1016/S0140-6736(09)61034-5

17. Dolgalyov I.V., Ivanova A.Yu., Karpov R.S. Prognosticheskaya znachimost' prediktorov serdechno-sosudistyh zabolevanij v formirovanii smertnosti ot serdechno-sosudistyh zabolevanij i ot vsekh prichin (rezul'taty 27-letnego kogortnogo prospektivnogo issledovaniya). [Prognostic significance of cardiovascular disease predictors in the formation of cardiovascular and all-cause mortality (results of a 27-year cohort prospective study).] Rossijskij kardiologicheskij zhurnal [Russian Journal of Cardiology] 2023; 28(2): 14-19, doi: 10.15829/1560-4071-2023-5045 (In Russ.)

18. Pure alcohol consumption, litres per capita, age 15+. European Health Information Gateway. Available at: https://gateway.euro.who.int/ru/indicators/hfa­_426-3050-pure-alcohol-consumption-litres-per-capita-age-15plus/#id=19443 Assessed: 12.02.2024

19. Saharov A.V., Govorin N.V. Sovremennye tendencii smertnosti naseleniya Zabajkal'skogo kraya ot zabolevanij, vyzvannyh upotrebleniem alkogolya. [Current trends in mortality of the population of Transbaikal Region from diseases caused by alcohol consumption.] Zabajkal'skij medicinskij vestnik [Transbaikal Medical Bulletin] 2016; (2): 59-65. (In Russ.)

20. Neufeld M., Ferreira-Borges C., Rehm J. Alcohol Policy Impact Case Study. The effects of alcohol control measures on mortality and life expectancy in the Russian Federation, WHO, 2019. ISBN: 978 92 890 5437 9.

21. Burcev A.A., Bedina I.A., Vlasovskih R.V., Zemskova N.N., Tihomirova N.V. Analiz dinamiki osnovnyh pokazatelej narkologicheskoj i somaticheskoj zabolevaemosti vzroslogo naseleniya g. Moskvy za 2017-2021 gg. [Analysis of the dynamics of the main indicators of narcological and somatic morbidity of the adult population of Moscow for 2017-2021.] Voprosy narkologii [Journal of Addiction Problems] 2023; 35(1): 64-74. (In Russ.)

22. Govorin N.V., Saharov A.V. Alkogol'noe bremya somaticheskogo stacionara. [Alcohol burden of somatic inpatients.] Tomsk: «Ivan Fedorov», 2010. (In Russ.)

23. Egorov A.Yu., Krupickij E.M., Sofronov A.G., Bobrov A.E., Tyavokina E.Yu., Dobrovol'skaya A.E. Zloupotreblenie alkogolem u bol'nyh, ekstrenno gospitalizirovannyh v bol'nicu skoroj pomoshchi. [Alcohol abuse in patients emergency hospitalized in an acute care hospital.] Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva [V.M. Bekhterev Review of Psychiatry and Medical Psychology] 2013; (1): 36-43. (In Russ.)

24. Babor T., Higgins-Biddle J., Saunders J., Monteiro M. The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. WHO, 2001.

25. Gual A., Segura L., Contel M., Heather N., Colom J. AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002; 37(6): 591-596, doi: 10.1093/alcalc/37.6.591

26. Petuhov A.E., Nadezhdin A.V., Bogstrand S.T., Bryun E.A., Ramenskaya G.V., Koshkina E.A., Mel'nik E.V., Smirnov A.V., Tetenova E.J. Fosfatidiletanol kak biomarker zloupotrebleniya alkogolem. [Phosphatidylethanol as the New Alcohol Abuse Biomarker.] Narkologiya [Narcology] 2017; (2): 42-47. (In Russ.)

27. Petuhov A.E., Mel'nik E.V., Nadezhdin A.V., Tetenova E.J., Suhanova A.M., Pankratenko E.P., Koshkina E.A. Razrabotka i validaciya metodiki kolichestvennogo opredeleniya fosfatidiletanola v cel'noj krovi. [Development and Validation of a Method for Quantitative Determination of Phosphatidylethanol in Whole Blood.] Medicina 2022; 10(3): 1-12, doi: 10.29234/2308-9113-2022-10-3-1-12 (In Russ.)

28. Helander A., Hansson T. National harmonization of the alcohol biomarker PEth. Lakartidningen 2013; (110): 1747-1748.

29. Kabashi S., Vindenes V., Bryun E.A., Koshkina E.A., Nadezhdin A.V., Tetenova E.J., Kolgashkin A.J., Petukhov A.E., Perekhodov S.N., Davydova E.N., Gamboa D., Hilberg T., Lerdal A., Nordby G., Zhang C., Bogstrand S.T. Harmful alcohol use among acutely ill hospitalized medical patients in Oslo and Moscow: A cross-sectional study. Drug Alcohol Depend. 2019; 204: 107588, doi: 10.1016/j.drugalcdep.2019.107588

30. Nadezhdin A.V., Tetenova E.J. Kolgashkin A.J., Petuhov A.E., Perekhodov S.N., Davydova E.N., Koshkina E.A., Koneva S.A., Koporov S.G., Bryun E.A. Prediktory lozhnootricatel'nyh rezul'tatov testa AUDIT-4 sredi pacientov mnogoprofil'noj klinicheskoj bol'nicy, gospitalizirovannyh po neotlozhnym pokazaniyam. [Predictors of False Negative AUDIT-4 Test Results Among Acutely Hospitalized Somatic Patients.] Narkologiya [Narcology] 2021; 20(10): 36-48, doi: 10.25557/1682-8313.2021.10.36-48 (In Russ.)

31. Nadezhdin A.V., Tetenova E.J., Kolgashkin A.J., Petuhov A.E., Davydova E.N., Kruzhalov A.N., Koshkina E.A. Kross-sekcionnoe issledovanie potrebleniya alkogolya s vrednymi posledstviyami u pacientov, gospitalizirovannyh po neotlozhnym pokazaniyam v nevrologicheskoe otdelenie mnogoprofil'nogo stacionara. [Cross-Sectional Study of Harmful Alcohol Consumption in Acutely Ill Neurological Patients of a General Hospital.] Medicina 2023; 11(1): 77-109, doi: 10.29234/2308-9113-2023-11-1-77-109 (In Russ.)

32. Jørgenrud B., Kabashi S., Nadezhdin A., Bryun E., Koshkina E., Tetenova E., Lerdal A., Norby G., Kolgashkin A., Petukhov A., Perekhodov S., Davydova E., Vindenes V., Gamboa D., Bogstrand S.T. The Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients. Alcohol Alcohol. 2021; 56(6): 726-736, doi: 10.1093/alcalc/agab013

33. Ostroumova O.D., Nikolaeva I.E., Eregin S.Ya., Pokrovskaya I.V., Ishchenko K.A. Upotreblenie alkogolya bol'nymi serdechno-sosudistymi zabolevaniyami (rezul'taty anketirovaniya kardiologicheskih bol'nyh v ambulatornoj praktike). [Alcohol Use by Patients with Cardiovascular Diseases (Results of Questionnaire Survey of Cardiology Patients in Outpatient Practice.)] Racional'naya farmakoterapiya v kardiologii [Rational pharmacotherapy in cardiology] 2015; 11(6): 582-589. (In Russ.)

34. Samorodskaya I.V., Kakorina E.P., Chernyavskaya T.K. Smertnost' ot alkogol'noj kardiomiopatii: fakticheskie dannye i problemy statisticheskogo ucheta. [Mortality from alcoholic cardiomyopathy: evidence and problems of statistical accounting.] Rossijskij kardiologicheskij zhurnal [Russian Journal of Cardiology] 2023; 28(11): 22-27, doi: 10.15829/1560-4071-2023-5498 (In Russ.)

35. Mirijello A., Tarli C., Vassallo G.A., Sestito L., Antonelli M., d'Angelo C., Ferrulli A., De Cosmo S., Gasbarrini A., Addolorato G. Alcoholic cardiomyopathy: What is known and what is not known. Eur J Intern Med. 2017; 43: 1-5, doi: 10.1016/j.ejim.2017.06.014

36. Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients 2020; 12(2): 572, doi: 10.3390/nu12020572

37. Briasoulis A., Agarwal V., Messerli F.H. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2012; 14(11): 792-798, doi: 10.1111/jch.12008

38. Larbi E.B., Stamler J., Dyer A., Cooper R., Paul O., Shekelle R.B., Lepper M. The population attributable risk of hypertension from heavy alcohol consumption. Public Health Rep. 1984; 99(3): 316-319.

39. Okojie O.M., Javed F., Chiwome L., Hamid P. Hypertension and Alcohol: A Mechanistic Approach. Cureus 2020; 12(8): e10086, doi: 10.7759/cureus.10086

40. Vacca A., Bulfone L., Cicco S., Brosolo G., Da Porto A., Soardo G., Catena C., Sechi L.A. Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story. Nutrients 2023; 15(4): 958, doi: 10.3390/nu15040958

41. Matsumoto C., Miedema M.D., Ofman P., Gaziano J.M., Sesso H.D. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev. 2014; 34(3): 159-171, doi: 10.1097/HCR.0000000000000042

42. Roerecke M., Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep. 2012; 14(6): 556-562, doi: 10.1007/s11883-012-0277-5